Cytokinetics Inc. buy UBS Group AG
Start price
03.04.23
/
50%
€34.60
Target price
03.04.24
€56.02
Performance (%)
87.86%
End price
04.04.24
€65.00
Summary
This prediction ended on 04.04.24 with a price of €65.00. With a performance of 87.86% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytokinetics Inc. | 6.422% | 6.422% | 69.591% | 74.699% |
| iShares Core DAX® | 4.852% | -2.747% | 13.097% | 46.787% |
| iShares Nasdaq 100 | 3.999% | -3.330% | 31.335% | 76.979% |
| iShares Nikkei 225® | 4.221% | -2.912% | 44.472% | 49.876% |
| iShares S&P 500 | 3.324% | -2.954% | 24.360% | 57.274% |
Comments by UBS_Group_AG for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at UBS Group AG from $67.00 to $61.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten